Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2026 18:48 ET | Source: Global Down Syndrome Foundation

GLOBAL Marks World Down Syndrome Day with Publication of Milestone Review of New Medical Guideline

DENVER, CO, March 20, 2026 (GLOBE NEWSWIRE) -- The Global Down Syndrome Foundation (GLOBAL) is proud to announce that the Agency for Healthcare Research and Quality (AHRQ) systemic review of the new...
March 20, 2026 14:52 ET | Source: California University of Science and Medicine

All California University of Science and Medicine MD Graduates Receive Residency Placements during Match Day 2026

Colton, California, March 20, 2026 (GLOBE NEWSWIRE) -- California University of Science and Medicine (CUSM) today announced that the 2026 MD graduating class received residency placements as part of...
March 19, 2026 10:28 ET | Source: Spherix Global Insights

CAR-T Moves Upstream in Multiple Myeloma as Physicians Signal Shift in Treatment Sequencing

Exton, PA, March 19, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights’ Q1 2026 update of RealTime Dynamix™: Multiple Myeloma findings point to a clear inflection in treatment strategy, as physicians...
March 18, 2026 22:42 ET | Source: Black Hawk Acquisition Corp.

Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer

BLACKHAWK, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Vesicor Therapeutics, Inc., a San Gabriel, California-based early development stage biotechnology corporation focused on the development of...
March 18, 2026 10:41 ET | Source: 24/7 Market News

Biotech Breakthroughs and Strategic Pivots Fuel Market Momentum

Biotech and healthcare innovators are advancing novel therapies and strategic platforms amid rising demand for targeted treatments and efficient global ac
March 18, 2026 08:07 ET | Source: Vanderbilt Report and Artelo Biosciences

Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study

Artelo Biosciences (NASDAQ: ARTL) enters ophthalmology space with a fully funded evaluating ART27.13 in glaucoma patients.
March 18, 2026 07:41 ET | Source: Artelo Biosciences

Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmology First patient enrollment anticipated in Q2 2026 SOLANA BEACH,...
March 18, 2026 07:00 ET | Source: OKYO Pharma LTD

OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain

LONDON and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
March 18, 2026 07:00 ET | Source: Harrow, Inc.

Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting

NASHVILLE, Tenn., March 18, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that three scientific...
March 17, 2026 11:28 ET | Source: Spherix Global Insights

Saphnelo Surpasses Benlysta in CLE as Physicians Expand Use of Biologics Ahead of Key 2027 Catalysts

Exton, PA, March 17, 2026 (GLOBE NEWSWIRE) -- As treatment strategies evolve in cutaneous lupus erythematosus (CLE), physicians are increasingly turning to advanced systemic therapies while...